Human fibrinogen - China Biologic Products

Drug Profile

Human fibrinogen - China Biologic Products

Latest Information Update: 11 Oct 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator China Biologic Products
  • Class Acute-phase proteins; Antihaemorrhagics; Blood coagulation factors; Coagulants
  • Mechanism of Action Fibrinogen replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Registered Afibrinogenaemia

Most Recent Events

  • 09 Oct 2017 Registered for Afibrinogenaemia in China (IV)
  • 09 Oct 2017 China Biologic intends to launch human Fibrinogen for Afibrinogenaemia by end of 2017
  • 25 Feb 2016 Preregistration for Afibrinogenaemia in China (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top